Total Payments
$57,850
2024 Payments
$812.19
Companies
19
Transactions
172
Medicare Patients
3,782
Medicare Billing
$962,635
Payment Breakdown by Category
Other$44,776 (77.4%)
Consulting$7,125 (12.3%)
Food & Beverage$4,504 (7.8%)
Travel$1,444 (2.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $44,776 | 16 | 77.4% |
| Consulting Fee | $7,125 | 4 | 12.3% |
| Food and Beverage | $4,504 | 150 | 7.8% |
| Travel and Lodging | $1,444 | 2 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $55,242 | 96 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $765.00 | 3 | $0 (2021) |
| Janssen Biotech, Inc. | $411.44 | 14 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $218.46 | 2 | $0 (2023) |
| Allergan Inc. | $196.16 | 6 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $167.69 | 20 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $142.17 | 7 | $0 (2024) |
| Celgene Corporation | $141.88 | 6 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $140.13 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $128.34 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $812.19 | 31 | ABBVIE INC. ($305.60) |
| 2023 | $17,496 | 37 | ABBVIE INC. ($17,199) |
| 2022 | $17,487 | 26 | ABBVIE INC. ($17,287) |
| 2021 | $7,718 | 11 | AbbVie Inc. ($7,464) |
| 2020 | $4,047 | 5 | AbbVie Inc. ($3,522) |
| 2019 | $9,604 | 33 | AbbVie, Inc. ($9,299) |
| 2018 | $423.54 | 18 | Intercept Pharmaceuticals, Inc. ($113.49) |
| 2017 | $261.20 | 11 | Allergan Inc. ($165.21) |
All Payment Transactions
172 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: Immunology | ||||||
| 12/16/2024 | ABBVIE INC. | CREON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $20.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: IMMUNOLOGY | ||||||
| 10/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Immunology | ||||||
| 10/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.48 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: Immunology | ||||||
| 09/25/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $26.64 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 09/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $21.93 | General |
| Category: Neuroscience | ||||||
| 09/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: IMMUNOLOGY | ||||||
| 07/30/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: IMMUNOLOGY | ||||||
| 07/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/18/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.40 | General |
| Category: Neuroscience | ||||||
| 06/14/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $89.60 | General |
| Category: Immunology | ||||||
| 06/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Immunology | ||||||
| 05/14/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.78 | General |
| Category: Neuroscience | ||||||
| 04/25/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $128.34 | General |
| 04/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: IMMUNOLOGY | ||||||
| 04/16/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: Immunology | ||||||
| 04/09/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.77 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 839 | 12,503 | $687,558 | $269,820 |
| 2022 | 21 | 1,141 | 16,436 | $936,841 | $361,390 |
| 2021 | 20 | 1,080 | 9,618 | $528,118 | $223,561 |
| 2020 | 20 | 722 | 2,194 | $399,381 | $107,865 |
Total Patients
3,782
Total Services
40,751
Medicare Billing
$962,635
Procedure Codes
84
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3380 | Injection, vedolizumab, 1 mg | Office | 2023 | 21 | 10,200 | $255,000 | $176,026 | 69.0% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 16 | 1,330 | $199,500 | $35,248 | 17.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 52 | 52 | $46,621 | $10,147 | 21.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 82 | 98 | $18,220 | $8,336 | 45.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 50 | 51 | $15,555 | $6,170 | 39.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 60 | 86 | $11,713 | $4,907 | 41.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 68 | $8,915 | $4,315 | 48.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 54 | 54 | $36,504 | $4,136 | 11.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 39 | 39 | $14,960 | $3,789 | 25.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 31 | 31 | $25,400 | $3,464 | 13.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $5,410 | $2,432 | 44.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 20 | 26 | $11,570 | $2,422 | 20.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 13 | 13 | $8,465 | $2,306 | 27.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 25 | 38 | $7,600 | $1,732 | 22.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 11 | 12 | $5,101 | $1,172 | 23.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 41 | 41 | $1,435 | $915.51 | 63.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 67 | 83 | $830.00 | $672.46 | 81.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 17 | 17 | $1,309 | $651.17 | 49.7% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 19 | 28 | $3,500 | $568.88 | 16.3% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 91 | 92 | $6,900 | $355.22 | 5.1% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 44 | 122 | $3,050 | $55.88 | 1.8% |
| J3380 | Injection, vedolizumab, 1 mg | Office | 2022 | 28 | 13,200 | $330,000 | $230,226 | 69.8% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2022 | 16 | 1,940 | $291,000 | $53,730 | 18.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 73 | 73 | $66,892 | $14,145 | 21.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 125 | 150 | $27,750 | $13,485 | 48.6% |
About Dr. Robert Gianotti, MD
Dr. Robert Gianotti, MD is a Gastroenterology healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2008. The National Provider Identifier (NPI) number assigned to this provider is 1356509574.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Gianotti, MD has received a total of $57,850 in payments from pharmaceutical and medical device companies, with $812.19 received in 2024. These payments were reported across 172 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($44,776).
As a Medicare-enrolled provider, Gianotti has provided services to 3,782 Medicare beneficiaries, totaling 40,751 services with total Medicare billing of $962,635. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Albany, NY
- Active Since 05/23/2008
- Last Updated 06/28/2016
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1356509574
Products in Payments
- SKYRIZI (Biological) $19,324
- RINVOQ (Biological) $14,376
- HUMIRA (Biological) $10,559
- STELARA (Biological) $1,078
- DUPIXENT (Biological) $239.28
- LINZESS (Drug) $151.56
- XIFAXAN (Drug) $151.32
- OCALIVA (Drug) $140.13
- Humira (Biological) $135.17
- ENTYVIO (Biological) $104.90
- TREMFYA (Drug) $98.43
- ZEPOSIA (Drug) $86.88
- CAPTIVATOR COLD (Device) $72.64
- Mavyret (Drug) $48.18
- Trulance (Drug) $47.82
- GATTEX (Drug) $39.01
- Resolution 360 Clip (Device) $34.17
- VIBERZI (Drug) $31.65
- CREON (Drug) $20.00
- REBYOTA (Biological) $18.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Albany
Bora Gumustop, M.d, M.D
Gastroenterology — Payments: $106,464
Gastroenterology $106,464
Mandeep Bhamra, M.d, M.D
Gastroenterology — Payments: $44,830
Gastroenterology $44,830
Dr. Jeffrey Gerson, Md, MD
Gastroenterology — Payments: $32,008
Gastroenterology $32,008
Joseph Polito, M.d, M.D
Gastroenterology — Payments: $8,726
Gastroenterology $8,726
Dr. Seth Richter, M.d, M.D
Gastroenterology — Payments: $7,843
Gastroenterology $7,843
Sajid Hussain, M.d, M.D
Gastroenterology — Payments: $5,078
Gastroenterology $5,078